Funder
Fundación Bancaria Caixa d’Estalvis i Pensions de Barcelona
Publisher
Springer Science and Business Media LLC
Reference10 articles.
1. Epstein JE, Tewari K, Lyke KE, Sim BK, Billingsley PF, Laurens MB, Gunasekera A, Chakravarty S, James ER, Sedegah M et al (2011) Live attenuated malaria vaccine designed to protect through hepatic CD8(+) T cell immunity. Science 334(6055):475–480. https://doi.org/10.1126/science.1211548
2. Franke-Fayard B (2022) Development and clinical evaluation of genetically attenuated parasite that arrests late in the liver. Oral presentation Tues, Nov 1, 10:45 am, 2022 Annual Meeting of the American Society for Tropical Medicine and Hygiene
3. Goswami D, Patel H, Betz W, Armstrong J, Camargo N, Patil A, Chakravarty S, Murphy SC, Sim BKL, Vaughan AM et al (2024) A replication competent Plasmodium falciparum parasite completely attenuated by dual gene deletion. EMBO Mol Med. https://doi.org/10.1038/s44321-024-00057-7
4. Moita D, Nunes-Cabaco H, Rola C, Franke-Fayard B, Janse CJ, Mendes AM, Prudencio M (2023) Variable long-term protection by radiation-, chemo-, and genetically-attenuated Plasmodium berghei sporozoite vaccines. Vaccine 41(51):7618–7625. https://doi.org/10.1016/j.vaccine.2023.11.023
5. Moita D, Rola C, Nunes-Cabaco H, Nogueira G, Maia TG, Othman AS, Franke-Fayard B, Janse CJ, Mendes AM, Prudencio M (2023) The effect of dosage on the protective efficacy of whole-sporozoite formulations for immunization against malaria. NPJ Vaccines 8(1):182. https://doi.org/10.1038/s41541-023-00778-9